Get the Stockscreener App
3.63
5.71%
-0.22
After Hours:
3.60
-0.03
-0.83%
Evoke Pharma Inc stock is traded at $3.63, with a volume of 37,713.
It is down -5.71% in the last 24 hours and up +39.62% over the past month.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$3.85
Open:
$3.7101
24h Volume:
37,713
Relative Volume:
0.02
Market Cap:
$5.42M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.3291
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-20.92%
1M Performance:
+39.62%
6M Performance:
-26.96%
1Y Performance:
-24.39%
1-Day Range:
$3.4501
$3.86
1-Week Range:
$3.4501
$4.6983
52-Week Range:
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
Name
Evoke Pharma Inc
Sector
Phone
858-345-1494
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Compare EVOK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
3.63 | 5.75M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-22-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-05-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-08-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Oct-19-17 | Resumed | FBR & Co. | Buy |
| Mar-16-17 | Reiterated | Rodman & Renshaw | Buy |
| Jan-30-17 | Upgrade | Laidlaw | Neutral → Buy |
| Jan-05-17 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Dec-23-16 | Reiterated | Rodman & Renshaw | Neutral |
| Jul-19-16 | Reiterated | FBR Capital | Outperform |
| Jul-19-16 | Downgrade | Noble Financial | Buy → Hold |
| Jul-18-16 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Mar-16-16 | Initiated | Northland Capital | Outperform |
| Mar-14-16 | Reiterated | Ascendiant Capital Markets | Buy |
| Feb-17-16 | Resumed | FBR Capital | Outperform |
| Dec-03-14 | Reiterated | MLV & Co | Buy |
| Nov-07-14 | Initiated | MLV & Co | Buy |
| Apr-22-14 | Initiated | Laidlaw | Buy |
| Nov-19-13 | Initiated | Aegis Capital | Buy |
View All
Evoke Pharma Inc Stock (EVOK) Latest News
Can a trend reversal in Evoke Pharma Inc. lead to recoverySmart Entry Signals for Active Traders - Newser
Will Evoke Pharma Inc. bounce back from current supportEntry Optimization Guide with Volume Analysis - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsTrade Safety Report with Pattern Insights - Newser
How sentiment analysis helps forecast Evoke Pharma Inc.Real-Time Entry Signals for Top Stocks - Newser
Why is Evoke Pharma Inc. stock attracting strong analyst attentionTop Growth Tips For Consistent Profits - jammulinksnews.com
Why Evoke Pharma Inc. stock attracts strong analyst attentionAI Volatility Forecast and Risk Monitor - Newser
Evoke Pharma (NASDAQ:EVOK) Is Using Debt Safely - simplywall.st
Why Evoke Pharma Inc. is moving todayShort-Term Trade Setup with Forecast Insight - Newser
Evoke Pharma Inc. Stock Support and Resistance Levels You Should KnowShort Term Trading Opportunity Watch Sees Shift - metal.it
Quant Models Detect Momentum Reversal in Evoke Pharma Inc.Risk Managed Intraday Trade Alerts Increase in Volume - metal.it
Applying chart zones and confluence areas to Evoke Pharma Inc.Ten-Year Sector Performance and Summary Analysis - Newser
How did EVOK's revenue surge in Q4 2024 despite rising expenses? - AInvest
Tools to monitor Evoke Pharma Inc. recovery probabilityRisk-Managed Trade Alerts for Consistency - Newser
Does Evoke Pharma Inc. stock perform well during market downturnsBuild wealth steadily with proven stock picks - jammulinksnews.com
Is it the right time to buy Evoke Pharma Inc. stockGet daily updates on the hottest stocks - jammulinksnews.com
What makes Evoke Pharma Inc. stock price move sharplyIdentify breakout stocks before they peak - jammulinksnews.com
Is NRx Pharmaceuticals Inc. stock bottoming out Free Target Return Focused Trade Insights - Newser
Real time scanner hits for Evoke Pharma Inc. explained Market Forecast Summary Over Multi-Year Period - Newser
How many analysts rate Evoke Pharma Inc. as a “Buy”Achieve consistent profits with smart trading - jammulinksnews.com
Is CVBF stock overvalued or undervaluedFree Daily Trading Room Entry - jammulinksnews.com
How does Evoke Pharma Inc. generate profit in a changing economyExplosive trading opportunities - jammulinksnews.com
How strong is LTBR company’s balance sheetConsistently superior profits - jammulinksnews.com
How volatile is Evoke Pharma Inc. stock compared to the marketGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What is the risk reward ratio of investing in Evoke Pharma Inc. stockInvest confidently with expert support - jammulinksnews.com
Published on: 2025-07-28 06:27:33 - jammulinksnews.com
Is Anebulo Pharmaceuticals Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - jammulinksnews.com
Monolithic Power Systems Inc. Company Revenue and Profit Trends: A Deep DiveMarket Ready Callouts - Newser
Delek US Holdings Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Investors Club - Newser
How Cardiff Oncology Inc. stock performs during market volatilityFree Stock Index Interpretation - Newser
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025Free Access to Community - Newser
Is Evoke Pharma Inc. Stock a Good Fit for Conservative InvestorsTop Performer Shortlist - Newser
When is Evoke Pharma Inc. stock expected to show significant growthExponential return rates - jammulinksnews.com
Is ARMOUR Residential REIT Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree AI-Powered Stock Predictions - Newser
Top Risks to Consider Before Buying Evoke Pharma Inc. StockShort Term High Return Strategy - Newser
What drives Ziff Davis Holdings Inc. Preferred Security stock priceFree Capital Growth Strategies - PrintWeekIndia
Will Evoke Pharma Inc. stock benefit from AI tech trendsDynamic capital growth - jammulinksnews.com
Balaxi Pharmaceuticals Limited (BALAXI) to Launch New Product LineExponential wealth increase - PrintWeekIndia
Evoke Pharma Inc. Stock Analysis and ForecastExceptional ROI - PrintWeekIndia
Best Gold Stocks to Buy AI Based Stock ScreeningFast-track wealth growth - Autocar Professional
What analysts say about Evoke Pharma Inc. stockOutperformance with explosive growth - Autocar Professional
Is Evoke Pharma Inc. a good long term investmentFree Investment Community - Autocar Professional
Is BJ s Restaurants Inc. a good long term investmentFree Wealth Planning Blueprint - jammulinksnews.com
Is YHGJ a good long term investmentRapidly expanding wealth - jammulinksnews.com
Paramount Communications Limited (PARACABLES) Quarterly Results Are OutOutperformance with explosive growth - jammulinksnews.com
Evoke Pharma Inc Stock (EVOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):